Bio-Rad Laboratories (BIO) Current Assets (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Current Assets for 18 consecutive years, with $3.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 7.45% year-over-year to $3.0 billion in Q2 2026; TTM through Jun 2026 was $3.0 billion, a 7.45% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, down 4.1% from the prior year.
• Current Assets was $3.0 billion for Q2 2026 at Bio-Rad Laboratories, up from $2.9 billion in the prior quarter.
• Over five years, Current Assets peaked at $3.3 billion in Q1 2022 and troughed at $2.8 billion in Q2 2025.
• A 5-year average of $3.1 billion and a median of $3.1 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 58.65% in 2022 and declined 8.02% in 2025, its largest moves.
• Over 5 years, Current Assets stood at $3.2 billion in 2022, then fell by 3.47% to $3.0 billion in 2023, then fell by 0.59% to $3.0 billion in 2024, then decreased by 4.1% to $2.9 billion in 2025, then advanced by 3.93% to $3.0 billion in 2026.
• The last three Current Assets figures came in at $3.0 billion (Q2 2026), $2.9 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.